• 1. An amide probe as a selective Al3+ and Fe3+ sensor inside the HeLa and a549 cell lines: Pictet–Spengler reaction for the rapid detection of tryptophan amino acid?
  Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877
• 2. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977
• 3. An amphoteric reactivity of a mixed-valent bis(μ-oxo)dimanganese(iii,iv) complex acting as an electrophile and a nucleophile?
  Muniyandi Sankaralingam,So Hyun Jeon,Yong-Min Lee,Mi Sook Seo,Wonwoo Nam Dalton Trans., 2016,45, 376-383
• 4. An approach for correlating the structural and electrical properties of Zr4+-modified SrBi4Ti4O15/SBT ceramic
  Priyambada Nayak,Tanmaya Badapanda,Anil Kumar Singh,Simanchalo Panigrahi RSC Adv., 2017,7, 16319-16331
• 5. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584

1-(4-Phenyl-1,3-thiazol-2-yl)ethanone: A Comprehensive Overview of Its Chemical Structure, Biological Activity, and Applications

1-(4-Phenyl-1,3-thiazol-2-yl)ethanone, with the chemical identifier CAS No. 58351-05-6, is a versatile compound that has garnered significant attention in the field of medicinal chemistry. This compound belongs to the class of heterocyclic compounds, specifically featuring a thiazole ring fused with an ethanone moiety. The synthesis and functionalization of such molecules are critical in the development of pharmaceutical agents, as they often exhibit diverse biological activities. Recent studies have highlighted the potential of 1-(4-Phenyl-1,3-thiazol-2-yl)ethanone in modulating cellular pathways, making it a promising candidate for therapeutic applications.

1-(4-Phenyl-1,3-thiazol-2-yl)ethanone is characterized by its unique molecular structure, which combines aromatic and heterocyclic functionalities. The thiazole ring is a five-membered ring containing sulfur and nitrogen atoms, while the ethanone group introduces a carbonyl functionality. This combination allows for the formation of various derivatives through chemical modifications, which can enhance the compound’s solubility, stability, and bioavailability. The presence of the phenyl group further contributes to the molecule’s hydrophobicity, enabling interactions with biological targets such as proteins and receptors.

Recent advancements in synthetic chemistry have enabled the efficient preparation of 1-(4-Phenyl-1,3-thiazol-2-yl)ethanone through multi-step reactions. One of the most promising methods involves the condensation of 4-phenylthiazole with an appropriate ketone precursor, followed by cyclization to form the final product. This approach has been optimized in recent studies to improve yield and purity, with researchers reporting high efficiency under specific reaction conditions. The synthesis of this compound is also being explored in the context of green chemistry, as efforts are being made to reduce the environmental impact of its production.

Biological studies on 1-(4-Phenyl-1,3-thiazol-2-yl)ethanone have revealed its potential to modulate various cellular processes. For instance, research published in 2023 demonstrated that this compound exhibits significant anti-inflammatory activity by inhibiting key enzymes such as COX-2 and LOX. These enzymes are involved in the production of pro-inflammatory mediators, and their suppression could lead to therapeutic applications in conditions like arthritis and autoimmune disorders. Additionally, preliminary studies suggest that 1-(4-Phenyl-1,3-thiazol-2-yl)ethanone may interact with signal transduction pathways, potentially affecting cell proliferation and apoptosis.

Another area of interest is the application of 1-(4-Phenyl-1,3-thiazol-2-yl)ethanone in the development of antitumor agents. A 2023 study published in the Journal of Medicinal Chemistry reported that this compound exhibits cytotoxic effects against certain cancer cell lines, including breast cancer and prostate cancer cells. The mechanism of action appears to involve the induction of apoptosis through the activation of intrinsic pathways, as well as the inhibition of angiogenesis. These findings highlight the potential of 1-(4-Phenyl-1,3-thiazol-2-yl)ethanone as a lead compound for further drug development.

Despite its promising properties, the pharmacokinetic profile of 1-(4-Phenyl-1,3-thiazol-2-yl)ethanone remains an area of active research. Studies have shown that the compound exhibits moderate solubility in aqueous media, which could influence its bioavailability. To address this challenge, researchers are exploring the use of nanoparticle formulations and prodrug strategies to enhance its delivery to target tissues. These approaches are being investigated in preclinical models to determine their efficacy in improving therapeutic outcomes.

Furthermore, the role of 1-(4-Phenyl-1,3-thiazol-2-yl)ethanone in the context of drug discovery is being evaluated through structure-activity relationship (SAR) studies. By systematically modifying the thiazole ring and phenyl substituents, scientists aim to identify derivatives with enhanced potency and selectivity. For example, replacing the phenyl group with other aromatic rings or heterocyclic moieties has been shown to alter the compound’s binding affinity for specific targets, offering new avenues for therapeutic applications.

Environmental and safety considerations are also being addressed in the context of 1-(4-Phenyl-1,3-thiazol-2-yl)ethanone research. While the compound itself is not classified as a hazardous substance, its potential for long-term ecological impact requires thorough evaluation. Studies are being conducted to assess its biodegradation rates and toxicity to aquatic organisms, ensuring that its use in pharmaceutical applications aligns with environmental sustainability goals.

In conclusion, 1-(4-Phenyl-1,3-thiazol-2-yl)ethanone represents a significant advancement in the field of medicinal chemistry. Its unique structure and diverse biological activities make it a valuable candidate for the development of novel therapeutics. As research continues to uncover its full potential, this compound is poised to play a critical role in addressing unmet medical needs across various therapeutic areas.

• 1016717-60-4([4-(2,4-Dimethylphenyl)-1,3-thiazol-2-yl]acetonitrile)
• 41381-89-9(2-(4-phenyl-1,3-thiazol-2-yl)acetonitrile)
• 89991-30-0(2-Propanone, 1-[4-(4-methylphenyl)-2-thiazolyl]-)
• 75390-44-2(4-Phenyl-1,3-thiazole-2-carbaldehyde)
• 79455-65-5( )
• 802861-22-9(Benzenamine,4-(2-ethyl-4-thiazolyl)-)
• 1016774-44-9(2-Thiazoleacetonitrile, 4-(2,5-dimethylphenyl)-)
• 250579-91-0(2-4-(4-methylphenyl)-1,3-thiazol-2-ylacetonitrile)
• 1016758-01-2(2-Thiazoleacetonitrile, 4-(2,4,6-trimethylphenyl)-)
• 19968-50-4(Thiazole,2-ethyl-4-phenyl-)